Mayumi Ito Selected Research

Mayumi Ito Research Topics

Disease

2	Thrombotic Microangiopathies 01/2022 - 01/2020
2	Vasculitis (Vasculitides) 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2002
2	Wounds and Injuries (Trauma) 01/2020 - 01/2013
2	Neoplasms (Cancer) 10/2016 - 05/2007
2	Cholesteryl Ester Transfer Protein Deficiency 08/2002 - 07/2002
1	Posterior Leukoencephalopathy Syndrome 01/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Hemolytic Anemia 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Glomerulonephritis 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Chronic Renal Insufficiency 01/2021
1	Vascular Calcification 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Systemic Scleroderma (Systemic Sclerosis) 01/2020
1	Melanoma (Melanoma, Malignant) 11/2019
1	Fibrosis (Cirrhosis) 09/2017
1	Cicatrix (Scar) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2016
1	Inflammation (Inflammations) 12/2013
1	Alopecia (Baldness) 01/2013
1	Carcinogenesis 05/2007
1	Atherosclerosis 09/2004
1	Coronary Disease (Coronary Heart Disease) 03/2004
1	Diabetes Mellitus 10/2003
1	Hyperlipidemias (Hyperlipidemia) 10/2003

Drug/Important Bio-Agent (IBA)

2	CateninsIBA 09/2017 - 12/2013
2	EnzymesIBA 09/2004 - 10/2003
2	Lipoproteins (Lipoprotein)IBA 09/2004 - 10/2003
2	HDL CholesterolIBA 03/2004 - 07/2002
2	CholesterolIBA 03/2004 - 07/2002
2	Cholesterol Ester Transfer ProteinsIBA 08/2002 - 07/2002
1	eculizumab FDA Link 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	FibrinIBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	MagnesiumIBA 01/2021
1	DisintegrinsIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	RNA Polymerase IIIIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ThrombospondinsIBA 01/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2020
1	Endothelins (Endothelin)IBA 11/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2017
1	Green Fluorescent ProteinsIBA 09/2017
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 09/2017
1	indium-bleomycinIBA 09/2017
1	Hydroxyproline (4 Hydroxyproline)IBA 09/2017
1	VimentinIBA 09/2017
1	istradefyllineIBA 09/2017
1	CollagenIBA 09/2017
1	PlasticsIBA 01/2017
1	Ifosfamide FDA LinkGeneric 10/2016
1	Calbindin 2IBA 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2016
1	LigandsIBA 01/2013
1	CarcinogensIBA 05/2007
1	Platelet Activating FactorIBA 09/2004
1	Phospholipids (Phosphatides)FDA LinkGeneric 09/2004
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 09/2004
1	Aryldialkylphosphatase (Paraoxonase)IBA 09/2004
1	Pre-beta High-Density LipoproteinsIBA 03/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Plasma Exchange 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Drug Therapy (Chemotherapy) 10/2016
1	Radiotherapy 10/2016